3Helix
3Helix, Inc.
3Helix's Collagen Hybridizing Peptides (CHP) can specifically bind to unfolded collagen molecules, by forming the triple helix with the denatured collagen chains. CHP is the first probe its kind to enable direct detection of denatured collagen molecules in virtually any tissue with mechanical damage
3helix.com · Salt Lake City, UT
Funding event
The round itself, as filedInferred stageSeries A
Sold of offered$7.8M of $10.0M
Filed2026-09-21
Days since filing12
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-08-31
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Michael KirknessExecutive Officer · Director
- Nalini D KellyDirector
- Michael FugmanDirector
- Noah NasserDirector
- Michael YuDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged78.4% sold1.1 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-220
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-02, against 71 in the 28 days before.